Conferences - Results from #11200

Viewing 11201-11220 of 11869 articles

ASCO 2013 - Podcast: Efficacy and safety of radium-223 dichloride in castration-resistant prostate cancer (CRPC) patients with bone metastases who did or did not receive prior docetaxel in the phase 3 ALSYMPCA trial

AUA 2013 - Cancer immunotherapy: Fundamental concepts and emerging role, urology perspective

ASCO 2013 - Poster: Evidence for a field effect in early prostate cancer (PCa): Gene expression profiles in normal-appearing prostate tissue (NT) adjacent to tumor (T) as predictors of clinical outcome

ASCO 2013 - Poster: Evidence for a field effect in early prostate cancer (PCa): Gene expression profiles in normal-appearing prostate tissue (NT) adjacent to tumor (T) as predictors of clinical outcome

ASCO 2013 - Poster: Inhibition of androgen receptor nuclear import by docetaxel, cabazitaxel, abiraterone and enzalutamide: a potential mechanism for cross-resistance in castration-resistant prostate cancer

ASCO 2013 - Poster: Inhibition of androgen receptor nuclear import by docetaxel, cabazitaxel, abiraterone and enzalutamide: a potential mechanism for cross-resistance in castration-resistant prostate cancer

ASCO 2013 - Podcast: Inhibition of androgen receptor nuclear import by docetaxel, cabazitaxel, abiraterone and enzalutamide: a potential mechanism for cross-resistance in castration-resistant prostate cancer

ASCO 2013 - Podcast: Inhibition of androgen receptor nuclear import by docetaxel, cabazitaxel, abiraterone and enzalutamide: a potential mechanism for cross-resistance in castration-resistant prostate cancer

ASCO 2013 - Poster: Impact of concomitant bone-targeted therapies on outcomes in metastatic castration-resistant prostate cancer patients without prior chemotherapy treated with abiraterone acetate or prednisone

ASCO 2013 - Podcast: Impact of concomitant bone-targeted therapies on outcomes in metastatic castration-resistant prostate cancer patients without prior chemotherapy treated with abiraterone acetate or prednisone

ASCO 2013 - Podcast: A discussion of the implementation and sequencing of treatment with sipuleucel-T for men with metastatic castration-resistant prostate cancer (mCRPC): Key messages from poster presentations at ASCO

ASCO 2013 - Slide Presentation: Localized and hormone sensitive prostate cancer: Best practices

ASCO 2013 - Slide Presentation: Localized and hormone sensitive prostate cancer: Best practices

ASCO 2013 - Podcast: Localized and hormone sensitive prostate cancer: Best practices

ASCO 2013 - Podcast: Localized and hormone sensitive prostate cancer: Best practices

ASCO 2013 - Slide Presentation: Efficacy and safety of enzalutamide (ENZA) monotherapy in hormone-naive prostate cancer (HNPC)

ASCO 2013 - Slide Presentation: Efficacy and safety of enzalutamide (ENZA) monotherapy in hormone-naive prostate cancer (HNPC)

ASCO 2013 - Podcast: Efficacy and safety of enzalutamide (ENZA) monotherapy in hormone-naive prostate cancer (HNPC)

ASCO 2013 - Slide Presentation: Prolaris: A novel genetic test for prostate cancer prognosis

ASCO 2013 - Slide Presentation: Prolaris: A novel genetic test for prostate cancer prognosis

556
557
558
559
560
561
562
563
564
565